120 related articles for article (PubMed ID: 15680433)
21. AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens.
Pistello M; Bonci F; Flynn JN; Mazzetti P; Isola P; Zabogli E; Camerini V; Matteucci D; Freer G; Pelosi P; Bendinelli M
J Virol; 2006 Sep; 80(18):8856-68. PubMed ID: 16940498
[TBL] [Abstract][Full Text] [Related]
22. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
Pu R; Omori M; Okada S; Rine SL; Lewis BA; Lipton E; Yamamoto JK
Cell Immunol; 1999 Nov; 198(1):30-43. PubMed ID: 10612649
[TBL] [Abstract][Full Text] [Related]
23. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
[TBL] [Abstract][Full Text] [Related]
24. New challenges for the diagnosis of feline immunodeficiency virus infection.
Crawford PC; Levy JK
Vet Clin North Am Small Anim Pract; 2007 Mar; 37(2):335-50, vii. PubMed ID: 17336678
[TBL] [Abstract][Full Text] [Related]
25. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.
Pistello M; Matteucci D; Bonci F; Isola P; Mazzetti P; Zaccaro L; Merico A; Del Mauro D; Flynn N; Bendinelli M
J Virol; 2003 Oct; 77(20):10740-50. PubMed ID: 14512524
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of a Texas feline immunodeficiency virus isolate: an emerging subtype of clade B.
Phadke AP; de la Concha-Bermejillo A; Wolf AM; Andersen PR; Baladandayuthapani V; Collisson EW
Vet Microbiol; 2006 Jun; 115(1-3):64-76. PubMed ID: 16574348
[TBL] [Abstract][Full Text] [Related]
27. Fetal feline immunodeficiency virus is prevalent and occult.
Rogers AB; Hoover EA
J Infect Dis; 2002 Oct; 186(7):895-904. PubMed ID: 12232829
[TBL] [Abstract][Full Text] [Related]
28. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
[TBL] [Abstract][Full Text] [Related]
29. Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses.
Paul TA; Casey JW; Avery RJ; Sutton CA
Virology; 2007 Apr; 361(1):112-22. PubMed ID: 17169394
[TBL] [Abstract][Full Text] [Related]
30. Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues.
Pistello M; Menzo S; Giorgi M; Da Prato L; Cammarota G; Clementi M; Bendinelli M
Mol Cell Probes; 1994 Jun; 8(3):229-34. PubMed ID: 7969197
[TBL] [Abstract][Full Text] [Related]
31. Low-dose interferon-alpha treatment for feline immunodeficiency virus infection.
Pedretti E; Passeri B; Amadori M; Isola P; Di Pede P; Telera A; Vescovini R; Quintavalla F; Pistello M
Vet Immunol Immunopathol; 2006 Feb; 109(3-4):245-54. PubMed ID: 16169599
[TBL] [Abstract][Full Text] [Related]
32. Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat.
Carpenter MA; Brown EW; MacDonald DW; O'brien SJ
Virology; 1998 Nov; 251(2):234-43. PubMed ID: 9837787
[TBL] [Abstract][Full Text] [Related]
33. Phylogenetic analysis suggests independent introduction of feline immunodeficiency virus clades A and B to Central Europe and identifies diverse variants of clade B.
Steinrigl A; Ertl R; Langbein I; Klein D
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):82-9. PubMed ID: 19910056
[TBL] [Abstract][Full Text] [Related]
34. IgG from acutely infected cats blocks mucosal feline immunodeficiency virus infection.
Burkhard MJ; Hoover EA
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):87-95. PubMed ID: 15910995
[TBL] [Abstract][Full Text] [Related]
35. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest.
Gemeniano MC; Sawai ET; Sparger EE
Virology; 2004 Aug; 325(2):167-74. PubMed ID: 15246256
[TBL] [Abstract][Full Text] [Related]
36. Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
Freer G; Giannecchini S; Tissot A; Bachmann MF; Rovero P; Serres PF; Bendinelli M
Virology; 2004 May; 322(2):360-9. PubMed ID: 15110533
[TBL] [Abstract][Full Text] [Related]
37. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
Richards JR
Biologicals; 2005 Dec; 33(4):215-7. PubMed ID: 16257536
[TBL] [Abstract][Full Text] [Related]
38. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase.
Lerner DL; Wagaman PC; Phillips TR; Prospero-Garcia O; Henriksen SJ; Fox HS; Bloom FE; Elder JH
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7480-4. PubMed ID: 7638216
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
Huisman W; Schrauwen EJ; Pas SD; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
Vaccine; 2008 May; 26(21):2553-61. PubMed ID: 18430494
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of hematological abnormalities and detection of infected bone marrow cells in asymptomatic cats with feline immunodeficiency virus infection.
Fujino Y; Horiuchi H; Mizukoshi F; Baba K; Goto-Koshino Y; Ohno K; Tsujimoto H
Vet Microbiol; 2009 May; 136(3-4):217-25. PubMed ID: 19110384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
